Creative Planning - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 315 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
Creative Planning ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2024$1,394,402
-30.8%
107,759
-25.7%
0.00%
-50.0%
Q1 2024$2,015,831
+33.1%
145,128
+36.8%
0.00%
-33.3%
Q4 2023$1,514,270
-21.7%
106,116
-15.1%
0.00%0.0%
Q3 2023$1,933,641
-3.0%
124,993
-1.5%
0.00%0.0%
Q2 2023$1,994,291
+22.0%
126,944
+28.0%
0.00%
+50.0%
Q1 2023$1,634,418
+58.6%
99,176
+50.1%
0.00%0.0%
Q4 2022$1,030,536
+18.0%
66,060
-1.9%
0.00%0.0%
Q3 2022$873,000
+47.0%
67,340
+59.3%
0.00%
+100.0%
Q2 2022$594,000
+13.6%
42,283
+15.8%
0.00%0.0%
Q1 2022$523,000
+22.8%
36,504
+16.9%
0.00%0.0%
Q4 2021$426,000
-26.3%
31,221
-11.5%
0.00%0.0%
Q3 2021$578,000
+6.1%
35,292
+8.9%
0.00%0.0%
Q2 2021$545,000
-31.8%
32,399
-26.0%
0.00%
-50.0%
Q1 2021$799,000
+25.6%
43,765
+25.2%
0.00%
+100.0%
Q4 2020$636,000
-33.2%
34,959
-34.5%
0.00%
-50.0%
Q3 2020$952,000
+17.8%
53,384
+18.5%
0.00%0.0%
Q2 2020$808,000
+9.2%
45,037
-7.6%
0.00%
-33.3%
Q1 2020$740,000
-23.3%
48,724
-0.4%
0.00%0.0%
Q4 2019$965,000
+8.3%
48,904
-5.6%
0.00%0.0%
Q3 2019$891,000
-2.3%
51,823
+0.6%
0.00%0.0%
Q2 2019$912,000
+18.3%
51,509
+36.2%
0.00%0.0%
Q1 2019$771,00037,8300.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2019
NameSharesValueWeighting ↓
Y.D. More Investments Ltd 1,498,811$24,700,3805.57%
TFG Asset Management GP Ltd 1,903,662$31,372,3504.20%
Clean Yield Group 542,342$8,937,7963.81%
MANAGED ASSET PORTFOLIOS, LLC 1,467,952$24,1923.67%
Mondrian Investment Partners LTD 4,081,715$67,266,6631.48%
Sippican Capital Advisors 82,235$1,355,2331.30%
Psagot Value Holdings Ltd. / (Israel) 174,300$2,8301.18%
Clal Insurance Enterprises Holdings Ltd 4,365,500$71,9431.08%
Legacy Wealth Asset Management, LLC 123,303$2,032,0330.73%
BRANDES INVESTMENT PARTNERS, LP 1,817,972$29,960,1750.64%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders